Worried about your State Pension income? Here are 2 FTSE 100 dividend stocks I’d buy today

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver improving income returns in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the State Pension amounting to just £8,767 per year, many retirees are likely to need a second income in older age.

Since the FTSE 100 appears to offer good value for money at the present time, with it having a dividend yield of around 4.5%, there are a number of opportunities to generate a growing passive income across the large-cap share universe.

With that in mind, here are two FTSE 100 stocks that could offer an improving income outlook, as well as relatively stable financial performance over the long term.

AstraZeneca

It’s been a difficult journey for pharmaceutical company AstraZeneca (LSE: AZN) over the last decade. It has seen its profitability fall heavily due to the loss of patents on key drugs, with this leading to a lack of dividend growth in recent years.

Now though, the company appears to be in a relatively strong position. It has invested heavily in its pipeline under a strategy that has sought to focus on core growth areas. This strategy is now expected to bear fruit, with the business forecast to post a rise in net profit of around 12% in the current year.

This could stimulate AstraZeneca’s dividend growth prospects, and lead to an improving income outlook for its investors. It now has a dividend yield of just 3.4%, but its potential to increase dividends at a pace that exceeds inflation could lead to a robust outlook from an income perspective.

Alongside this, the company’s defensive appeal could help it to outperform the wider FTSE 100 at a time when the prospects for the global economy remain highly uncertain.

Unilever

Unilever’s (LSE: ULVR) recent updates have shown that its current growth strategy is paying off. It has focused investment on fast-growing markets across the emerging world, with them now making up the lion’s share of its revenue. They are also the main catalyst behind the company’s growth rate, and are likely to remain so over the medium term as wages in countries such as China move higher at a rapid rate.

Like AstraZeneca, Unilever’s dividend yield is below that of the wider FTSE 100 at the present time. The consumer goods company is set to record an income return of just 2.9% in the current year. However, with its bottom line forecast to produce a gain of 10% this year and its dividend payments being covered 1.6 times by profit, the scope for a rapidly-rising dividend seems to be high.

Although Unilever may lack the defensive appeal of some of its FTSE 100 peers, its potential to enjoy above-average growth over the long run seems to be high. It has a wide range of popular brands in a number of different markets. This provides it with a wide economic moat which, alongside its growth potential, makes it an enticing income opportunity for the long term.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca and Unilever. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

Just released: our 3 top small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Happy African American Man Hugging New Car In Auto Dealership
Investing Articles

Has Lloyds (and its share price) had a lucky escape?

Following an announcement by the Financial Conduct Authority, investors breathed a sigh of relief and sent the Lloyds share price…

Read more »

Mother and Daughter Blowing Bubbles
Investing Articles

Why the next stock market crash could be this decade’s best buying opportunity

This Fool explains why he's waiting on the sidelines for the right moment as a stock market crash could finally…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Growth Shares

2 growth stocks with P/E ratios below the FTSE 100 average

Jon Smith points out a couple of growth stocks that look attractively valued when he considers each company's future outlook.

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Growth Shares

Here’s how the motor finance scandal could impact Lloyds shares long term

Jon Smith comments on the latest news out regarding the motor finance investigation and talks through long-term implications for Lloyds…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Lloyds shares drop on car loan news! Is this a dip-buying opportunity?

Lloyds shares have dropped after it warned of higher provisions for the mis-selling of car loans. Is the FTSE 100…

Read more »

Hand flipping wooden cubes for change wording" Panic" to " Calm".
Investing Articles

The HSBC share price isn’t having a good day, but I don’t think shareholders should be alarmed

Our writer reflects on today’s (9 October) fall in the HSBC share price. But he still thinks the UK’s most…

Read more »

Two mid adult women enjoying a friends reunion city break for the weekend in Newcastle upon Tyne, England.
Investing Articles

Prediction: analysts say the Taylor Wimpey share price will climb 31% in a year! Really?

Harvey Jones is bowled over by optimistic forecasts for the Taylor Wimpey share price, and there's plenty of income on…

Read more »